The addition of S100B to guidelines for management of mild head injury is potentially cost saving

BACKGROUND: Mild traumatic brain injury (TBI) is associated with substantial costs due to over-triage of patients to computed tomography (CT) scanning, despite validated decision rules. Serum biomarker S100B has shown promise for safely omitting CT scans but the economic impact from clinical use has...

Descripción completa

Detalles Bibliográficos
Autores principales: Calcagnile, Olga, Anell, Anders, Undén, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073952/
https://www.ncbi.nlm.nih.gov/pubmed/27765016
http://dx.doi.org/10.1186/s12883-016-0723-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073952/
https://www.ncbi.nlm.nih.gov/pubmed/27765016
http://dx.doi.org/10.1186/s12883-016-0723-z

Ejemplares similares